These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26500103)

  • 1. Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors.
    Singh P; Sharma B
    Curr Neurovasc Res; 2016; 13(1):10-21. PubMed ID: 26500103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effects of Nicorandil in Chronic Cerebral Hypoperfusion-Induced Vascular Dementia.
    Gupta S; Singh P; Sharma B
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2717-2728. PubMed ID: 27622862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia.
    Gupta S; Singh P; Sharma B
    Curr Hypertens Rev; 2024; 20(1):23-35. PubMed ID: 38192137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
    Jayant S; Sharma B
    Curr Neurovasc Res; 2016; 13(4):289-302. PubMed ID: 27586843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia.
    Gupta S; Sharma B; Singh P; Sharma BM
    Curr Neurovasc Res; 2014 May; 11(2):94-106. PubMed ID: 24597602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury.
    Singh P; Sharma B
    Curr Neurovasc Res; 2016; 13(2):135-46. PubMed ID: 26915517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.
    Gupta S; Singh P; Sharma BM; Sharma B
    Curr Neurovasc Res; 2015; 12(3):240-52. PubMed ID: 26036976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia.
    Jayant S; Sharma B
    Curr Neurovasc Res; 2016 Sep; ():. PubMed ID: 27599483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
    Saad MA; Abdelsalam RM; Kenawy SA; Attia AS
    Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
    Gupta S; Sharma B
    Eur J Pharmacol; 2014 Jan; 723():80-90. PubMed ID: 24333661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cerebral perfusion and oxidative stress result in acute and delayed cognitive impairment.
    Liu H; Zhang J; Yang Y; Zhang L; Zeng X
    Curr Neurovasc Res; 2012 Aug; 9(3):152-8. PubMed ID: 22621229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats.
    Damodaran T; Müller CP; Hassan Z
    Pharmacol Rep; 2019 Jun; 71(3):443-448. PubMed ID: 31003155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
    Jain S; Sharma B
    Physiol Behav; 2016 Oct; 164(Pt A):140-50. PubMed ID: 27262216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion.
    Xi Y; Wang M; Zhang W; Bai M; Du Y; Zhang Z; Li Z; Miao J
    Neurobiol Learn Mem; 2014 Mar; 109():7-19. PubMed ID: 24315928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
    Singh P; Gupta S; Sharma B
    Curr Neurovasc Res; 2016; 13(3):219-29. PubMed ID: 27189349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.